Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate level and seizure quality during electroconvulsive therapy
NL-OMON33180Active, not recruiting
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of etomidate in major depressive disorder (MDD), sponsored by Elisabeth-TweeSteden Ziekenhuis. Primary endpoint: Seizure quality. Started Dec 2009; status: active, not recruiting.
02
Drugs
etomidate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON33180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33180.